398 related articles for article (PubMed ID: 19274661)
21. The potential impact of structural genomics on tuberculosis drug discovery.
Arcus VL; Lott JS; Johnston JM; Baker EN
Drug Discov Today; 2006 Jan; 11(1-2):28-34. PubMed ID: 16478688
[TBL] [Abstract][Full Text] [Related]
22. ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection.
Simeone R; Bottai D; Frigui W; Majlessi L; Brosch R
Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S150-4. PubMed ID: 25732627
[TBL] [Abstract][Full Text] [Related]
23. Lipid hydrolizing enzymes in virulence: Mycobacterium tuberculosis as a model system.
Singh G; Singh G; Jadeja D; Kaur J
Crit Rev Microbiol; 2010 Aug; 36(3):259-69. PubMed ID: 20500016
[TBL] [Abstract][Full Text] [Related]
24. Lipolytic enzymes in Mycobacterium tuberculosis.
Côtes K; Bakala N'goma JC; Dhouib R; Douchet I; Maurin D; Carrière F; Canaan S
Appl Microbiol Biotechnol; 2008 Apr; 78(5):741-9. PubMed ID: 18309478
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetics of Mycobacterium tuberculosis pathogenesis.
Clark-Curtiss JE; Haydel SE
Annu Rev Microbiol; 2003; 57():517-49. PubMed ID: 14527290
[TBL] [Abstract][Full Text] [Related]
26. The rise and fall of the Mycobacterium tuberculosis genome.
Veyrier FJ; Dufort A; Behr MA
Trends Microbiol; 2011 Apr; 19(4):156-61. PubMed ID: 21277778
[TBL] [Abstract][Full Text] [Related]
27. Structural proteomics and computational analysis of a deadly pathogen: combating Mycobacterium tuberculosis from multiple fronts.
Strong M; Goulding CW
Methods Biochem Anal; 2006; 49():245-69. PubMed ID: 16929683
[No Abstract] [Full Text] [Related]
28. Analyzing the interaction of pathogens with the host immune system.
Jayachandran R; Scherr N; Pieters J
Immunol Lett; 2009 Feb; 122(2):112-4. PubMed ID: 19135088
[TBL] [Abstract][Full Text] [Related]
29. A review of vaccine research and development: tuberculosis.
Girard MP; Fruth U; Kieny MP
Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
[TBL] [Abstract][Full Text] [Related]
30. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
Anishetty S; Pulimi M; Pennathur G
Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
[TBL] [Abstract][Full Text] [Related]
31. Pathogenomics of mycobacteria.
Gutierrez MC; Supply P; Brosch R
Genome Dyn; 2009; 6():198-210. PubMed ID: 19696503
[TBL] [Abstract][Full Text] [Related]
32. Genes and regulatory networks involved in persistence of Mycobacterium tuberculosis.
Wang X; Wang H; Xie J
Sci China Life Sci; 2011 Apr; 54(4):300-10. PubMed ID: 21267668
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol oxidase is required for virulence of Mycobacterium tuberculosis.
Brzostek A; Dziadek B; Rumijowska-Galewicz A; Pawelczyk J; Dziadek J
FEMS Microbiol Lett; 2007 Oct; 275(1):106-12. PubMed ID: 17651430
[TBL] [Abstract][Full Text] [Related]
34. Shared Pathogenomic Patterns Characterize a New Phylotype, Revealing Transition toward Host-Adaptation Long before Speciation of Mycobacterium tuberculosis.
Sapriel G; Brosch R
Genome Biol Evol; 2019 Aug; 11(8):2420-2438. PubMed ID: 31368488
[TBL] [Abstract][Full Text] [Related]
35. Tubercle bacilli rely on a type VII army for pathogenicity.
Stoop EJ; Bitter W; van der Sar AM
Trends Microbiol; 2012 Oct; 20(10):477-84. PubMed ID: 22858229
[TBL] [Abstract][Full Text] [Related]
36. Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae.
Dover LG; Cerdeño-Tárraga AM; Pallen MJ; Parkhill J; Besra GS
FEMS Microbiol Rev; 2004 May; 28(2):225-50. PubMed ID: 15109786
[TBL] [Abstract][Full Text] [Related]
37. Evolution of Mycobacterium tuberculosis: New Insights into Pathogenicity and Drug Resistance.
Boritsch EC; Brosch R
Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27787194
[TBL] [Abstract][Full Text] [Related]
38. Genomic determinants of speciation and spread of the
Chiner-Oms Á; Sánchez-Busó L; Corander J; Gagneux S; Harris SR; Young D; González-Candelas F; Comas I
Sci Adv; 2019 Jun; 5(6):eaaw3307. PubMed ID: 31448322
[TBL] [Abstract][Full Text] [Related]
39. Identifying sigma factors in Mycobacterium smegmatis by comparative genomic analysis.
Waagmeester A; Thompson J; Reyrat JM
Trends Microbiol; 2005 Nov; 13(11):505-9. PubMed ID: 16140533
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis in tuberculosis: transcriptomic approaches to unraveling virulence mechanisms and finding new drug targets.
Mukhopadhyay S; Nair S; Ghosh S
FEMS Microbiol Rev; 2012 Mar; 36(2):463-85. PubMed ID: 22092372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
